Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

Clinical trial NCT03646461 · TERMINATED

Trial details

NCT number: NCT03646461
Sponsor: University of California, San Diego
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma of the Head and Neck

Start date: 2018-10-17
Primary completion: 2020-08-15
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.